Skip to content
V-Biognostics
Toggle menu
  • About
  • Contact
  • Products
    • Osteocalcin (1-49) Human (Synthetic)
    • Antibiotics
      • Amphotericin B (Fungizone)
      • Bestatin (Ubenimex)
      • Bleomycin Sulfate
      • Brefeldin A
      • Daptomycin
      • G418, Sulfate
      • Mitomycin C
      • Thiostrepton
      • Valinomycin
    • Protease Inhibitors 1
      • AEBSF
      • Alafosfalin (Synthetic)
      • ALLN (Calpain Inh. I)
      • ALLM (Calpain Inh. II)
      • Amastatin, HCl
      • Antipain, 2HCl
      • Bestatin, HCl
      • Calpain Inh. III
      • Calpeptin
    • Protease Inhibitors 2
      • E-64 (Synthetic)
      • E-64d
      • Elastase Inh. I
      • Leupeptin, HCl
      • Leupeptin, Hemisulfate
      • MG-132
      • Pepstatin A
      • Phosphoramidon
      • RG108
      • TLCK, HCl
  • GERBU
    • GERBU Esterquat Product List
    • GERBU Adjuvant Product List
    • GERBU Adjuvant Introduction
    • GERBU Adjuvants Product Manuals
  • Articles
  • Email Logo

Category: News

November 1, 2019News

#BIOSummit19: Education and Partnerships Raise Awareness

BIOtech Now Theresa Brady When Mark Dant’s son Ryan was first diagnosed with MPS-I, a rare genetic disorder that leads to organ […]

October 28, 2019News

Greenwood: Solving the Looming Superbug Crisis Will Require Bold Action From Congress

BIOtech Now Andrew Segerman Writing for Morning Consult, BIO’s Jim Greenwood discusses the challenges of developing novel antibiotics and highlights the urgent […]

October 23, 2019News

Fundraising Companies Find Strategic Partners that Best Fit Their Stage of Development at BIO Investor Forum

BIOtech Now Rufael Seyum Since its inception 17 years ago, the BIO Investor Forum has become the premier event where biotech innovators […]

October 22, 2019News

Investment Crackdown Prompts Chinese Investors to Leave U.S. Biotech Market and Focus on Europe

BIOtech Now Rufael Seyum Confusion among Chinese investors about shifting U.S. regulatory policy is draining billions of dollars from the American biotechnology […]

October 10, 2019News

BIO Mourns Passing of Dr. John Holaday

BIOtech Now Jim Greenwood On behalf of the team at BIO, we send our deepest condolences to the family of Dr. John […]

September 19, 2019News

#TBT: Debunking Some Common Myths on Patent Protections

BIOtech Now Andrew Segerman The Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce is set to examine […]

September 17, 2019News

The Challenges and Risks of Adopting Foreign Price Controls

BIOtech Now Andrew Segerman The Trump Administration is moving forward with a plan to import foreign price controls into Medicare. Under the […]

September 12, 2019News

As Mosquito Fears Rise, EPA Considers Oxitec 2nd Generation Trial

BIOtech Now Karen Batra Most people consider mosquitoes to be a summertime pest – the unwelcome guest at the backyard barbecue. More […]

September 5, 2019News

ICYMI: Biopharmaceutical Companies Aren’t Free-Riding on Government Research

BIOtech Now Andrew Segerman Writing for the Boston Globe, Dr. Michael Rosenblatt, chief medical officer of the venture firm Flagship Pioneering, debunks […]

August 29, 2019News

Discrimination Against Vulnerable Patients Is Nothing New

BIOtech Now Andrew Segerman Transformative therapies are advancing like never before, and a new class of medicines are changing the way we […]

August 27, 2019News

National Immunization Awareness Month Is a Reminder About the Value of Vaccines

BIOtech Now Andrew Segerman Writing for Morning Consult, Dr. Judy Monroe, president and CEO of the CDC Foundation, highlights the importance of […]

August 22, 2019News

The BIO Investor Forum Links Promising Early-Stage Technologies with an Active Investor Network

BIOtech Now Nareg Sagherian As the biopharma industry has gained traction on new drug approvals throughout 2019, the financial dollars have followed […]

August 21, 2019News

New Coalition to Raise Awareness of Antimicrobial Resistance Threat, Call for Urgent Solutions

BIOtech Now Andrew Segerman The Biotechnology Innovation Organization (BIO), leading scientists, public policy experts, and industry leaders today announced the launch of […]

August 20, 2019News

BIO’s Jim Greenwood Talks Pricing, Policy and Science on CSPAN

BIOtech Now Andrew Segerman BIO’s Jim Greenwood joined CSPAN’s Washington Journal for a conversation about drug pricing, the latest proposals being considered […]

August 6, 2019News

Biotech Leaders Warn: Shortsighted Policies Threaten Miracle Breakthroughs

BIOtech Now Andrew Segerman Writing for STAT News, Paul Hastings – CEO of Nkarta Therapeutics and Vice Chair of BIO’s Board – […]

August 5, 2019News

Why Are Patients Facing Higher Costs When They Go to the Pharmacy?

BIOtech Now Andrew Segerman BIO is out with a new whiteboard video that explores why more and more patients are facing higher […]

July 31, 2019News

Technology to Fight Malaria, Zika, and Other Mosquito-Related Diseases Is Being Blocked. Why?

BIOtech Now Josh Falzone Every year, mosquitos infect 500 million people with diseases and mosquito-borne illnesses claim nearly a million lives. Mosquito-related […]

July 24, 2019News

Experts Weigh In on the Dangers of Importing Foreign Price Controls

BIOtech Now Andrew Segerman Experts recently gathered on Capitol Hill to discuss how importing foreign price controls will lead to less innovation […]

July 19, 2019News

New Videos Show How “Fail First” Policies Can Fail Patients

BIOtech Now BIOtechNOW Editor Continued access to a stable treatment can make all the difference for patients with chronic illnesses like arthritis, […]

July 16, 2019News

Rare Disease Drug Development Increases but Challenges Remain

BIOtech Now Andrew Segerman In a recent study published by Tufts University, researchers found that rare disease drug development is now one […]

Posts navigation

< 1 … 30 31 32 … 47 >
Partnering with:   Quartett GERBU Adjuvants

V-BIOGNOSTICS, "Ingredients For Life" is a BioTech company devoted to research in life science reagents worldwide. We source difficult to find biochemicals for the advancement in research of antibody production, Immunohistochemistry, drug development, molecular biology, cell biology, cancer research, Immunotherapy, Oncology, drug discovery, and agricultural biotechnology. We work hard for speedy processing and delivery of your products and at very competitive pricing offering you a high quality alternative to big pharma for your sourcing and manufacturing needs.

D&B VERIFIED Seal

We Supply the highest quality protease inhibitors, antibiotics, and Adjuvants including: Bestatin HCl, Leupeptin Hemisulfate / Hydrochloride, AEBSF, G418, Elastatinal, E-64, Pepstatin, Calpain, Bleomycin Sulfate, Proteinase K, MG-132, ALLM, ALLN, Antipain, Anti-Human Rabbit IgG, GERBU Monoclonal/Polyclonal Adjuvant, synthetic and custom synthesis. Please Contact Us or visit our Products, About, or Terms pages for more information.

Biotech Articles

  • How can proteomic analysis improve our understanding of the ageing process. Find out in your latest issue of BioTechniques!
  • Mutated gene is the driver of psoriasis
  • The latest developments in microbiology from a diverse cast of characters
  • Scientists stymie sarcopenia
  • Decoding the neuroanatomical signature of developmental language disorder
  • Lac-Phe: the mechanism behind metformin’s role in weight loss
© 2025 V-Biognostics. Proudly powered by Sydney